Hyloris Pharmaceuticals S.A.
HYL.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€6,342 | -€15,380 | -€10,770 | -€11,579 |
| Dep. & Amort. | €1,229 | €348 | €196 | €137 |
| Deferred Tax | €0 | -€294 | €0 | €196 |
| Stock-Based Comp. | -€540 | €540 | €560 | €576 |
| Change in WC | -€1,278 | €2,234 | -€3,375 | -€777 |
| Other Non-Cash | €228 | -€256 | €235 | €197 |
| Operating Cash Flow | -€6,703 | -€12,808 | -€13,154 | -€11,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€29 | -€298 | -€739 | -€1,061 |
| Net Acquisitions | €0 | €0 | €0 | -€1,270 |
| Inv. Purchases | €0 | €0 | -€500 | -€1,178 |
| Inv. Sales/Matur. | €0 | €10,000 | €522 | €216 |
| Other Inv. Act. | €288 | €187 | -€522 | €218 |
| Investing Cash Flow | €259 | €9,889 | -€1,239 | -€3,075 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€168 | €51 | -€7,376 | -€62 |
| Stock Issued | €0 | €0 | €17,169 | €0 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€200 | -€182 | -€1,955 | €0 |
| Financing Cash Flow | -€368 | -€131 | €7,838 | -€62 |
| Forex Effect | €0 | -€1 | €0 | €0 |
| Net Chg. in Cash | -€6,812 | -€3,051 | -€6,555 | -€14,387 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €30,406 | €33,457 | €50,012 | €64,399 |
| End Cash | €23,594 | €30,406 | €43,457 | €50,012 |
| Free Cash Flow | -€6,732 | -€13,106 | -€13,893 | -€12,311 |